A Comparison of PET Tracers in Recurrent High-Grade Gliomas: A Systematic Review

Humans with high-grade gliomas have a poor prognosis, with a mean survival time of just 12–18 months for patients who undergo standard-of-care tumor resection and adjuvant therapy. Currently, surgery and chemoradiotherapy serve as standard treatments for this condition, yet these can be complicated...

Descripción completa

Detalles Bibliográficos
Autores principales: Muthukumar, Sankar, Darden, Jordan, Crowley, James, Witcher, Mark, Kiser, Jackson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820099/
https://www.ncbi.nlm.nih.gov/pubmed/36613852
http://dx.doi.org/10.3390/ijms24010408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820099/
https://www.ncbi.nlm.nih.gov/pubmed/36613852
http://dx.doi.org/10.3390/ijms24010408

Ejemplares similares